CD44 and ovarian carcinoma: Moreover, 9/25 samples analyzed showed PDGFβ-R expression, and all 9 were M-type (Figure2A and not shown), and 8/9 samples expressing PDGFβ-R also expressed the ovarian cancer TIC marker CD44 and high levels of stem cell transcription factor Oct-4A (not shown and see below).